Herbal Leaf MarketKnow the Facts
Education & Advocacy

The Hemp Law Is Changing.
Here Are the Facts.

A plain-language, fully sourced guide to the 2018 Farm Bill, the 2025 law that rewrote it, and what the November 12, 2026 hemp definition change means for the non-intoxicating CBD & CBG that families rely on.

⏳— until enforcement begins (Nov 12, 2026)
Educational information, not medical or legal advice. Nothing here is a claim that any product diagnoses, treats, cures, or prevents disease — these statements have not been evaluated by the FDA. Do not start, stop, or change any treatment without your licensed healthcare provider. Laws vary by state and are changing; consult a qualified attorney for legal questions.

The 60-Second Version

  • What: A 2025 federal law rewrote the definition of "hemp," changing it from a delta-9-only standard to a total-THC standard and capping finished products at 0.4 mg total THC per container.[3][4]
  • When: Signed November 12, 2025; enforcement begins November 12, 2026 — a one-year runway to adapt or seek a fix.[1][2]
  • The catch: Industry & policy analysts estimate it would make ~90–95% of hemp products federally unlawful — including most full-spectrum CBD, not just intoxicating "gas-station" items.[4][5]
  • The opening: The executive branch itself acknowledged the language would "inadvertently recriminalize full-spectrum non-intoxicating CBD" and asked Congress to fix it.[5] That's the reform window we're advocating in.

How We Got Here

  • 2018 — The Farm Bill
    The Agriculture Improvement Act defined hemp as cannabis with ≤0.3% delta-9 THC by dry weight, legalizing CBD and hemp farming. Because it named only delta-9, it unintentionally left the door open for delta-8, THCA, and other cannabinoids.[1]
  • 2018–2025 — The "loophole" market
    An estimated $28B market of hemp-derived intoxicants (delta-8 vapes, THCA flower, etc.) grew with little federal oversight, prompting pushback from lawmakers and state officials.[1]
  • November 12, 2025 — The law changes
    Section 781 of H.R. 5371 (Continuing Appropriations Act, 2026) was signed, rewriting the hemp definition. It passed inside a must-pass government-funding bill rather than standalone debate.[2][3]
  • November 12, 2026 — Enforcement begins
    The new total-THC definition and 0.4 mg cap take effect. As of now, absent a legislative fix, ~90–95% of current products become federally unlawful.[2][4]

What Actually Changed

 2018 Farm Bill2025 Law (Sec. 781)
THC measured asDelta-9 THC onlyTotal THC (delta-9 + THCA + delta-8, etc.)
Finished-product cap≤0.3% delta-9 by dry weight≤0.4 mg total THC per container
Lab-converted cannabinoidsNot addressedExplicitly excluded (e.g., most delta-8)

Sources: Forbes analysis of H.R. 5371 §781;[3] Vicente LLP;[4] ProCannabis explainer.[6]

What likely stays vs. what's swept up

ProductStatus under the new definition
Intoxicating delta-8 / delta-10 / THC-OTargeted Banned (lab-converted & over cap)
THCA flowerTargeted Counts toward total THC
Full-spectrum CBD oils & gummies (trace THC)Swept up Most exceed 0.4 mg/container[5]
Broad-spectrum / THC-free CBD & CBG isolateMore likely OK If truly non-detectable THC
An honest nuance: "Full-spectrum" CBD often contains a trace, non-intoxicating amount of THC that is essential to how the product works — and that trace is exactly what pushes many wellness products past the 0.4 mg cap. This is why advocates argue for smart regulation (age limits, testing, dose caps on intoxicants) rather than a blanket cap that erases non-intoxicating medicine.[5]

What the Science Actually Says

We only cite what's supportable. Here's the honest state of the evidence for the non-intoxicating cannabinoids at the heart of this fight:

CBD for seizures — strongest evidence

Purified CBD (Epidiolex) is FDA-approved for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients 1 year and older — the first and only FDA-approved prescription CBD.[7][8] This is real, peer-reviewed, regulator-backed science.

FDA approved Epidiolex June 25, 2018 (Dravet & LGS), later adding TSC.[8]

CBD for anxiety — promising, still maturing

A widely cited review in Neurotherapeutics found existing evidence supports CBD's potential for generalized anxiety, panic, social anxiety, OCD, and PTSD — strongest for acute dosing, with fewer long-term studies.[9] We describe this as "promising," not "proven."

CBG for anxiety & stress — early clinical signal

The first human clinical trial of CBG (Washington State University, Scientific Reports, 2024) found 20 mg of hemp-derived CBG significantly reduced anxiety and stress vs. placebo, without intoxication.[10] One small, rigorous study — encouraging, and a reason not to ban it.

Where we stay careful: Evidence for cannabinoids in bipolar disorder and BPD is limited, and THC specifically can worsen mania or psychosis in some people. We share lived experiences for those conditions as personal stories, never as treatment claims — and we always encourage working with a licensed provider and never stopping prescribed medication on your own.

Who This Affects

This isn't a fringe or "recreational" issue. Reporting during recent state and federal ban fights documents the real people at stake:

"He's been seizure-free for 10 years… on a non-intoxicating product." — Stephanie Fokas, whose son Reagan turned to CBD after brain surgery and pharmaceuticals failed to control his epilepsy.
Reported by WFAA / FOX, 2025–2026.[11][12]
Veterans have described using regulated hemp products as a safer alternative to prescription "cocktails" of as many as 30 pills a day for PTSD and pain.
Austin American-Statesman Editorial Board, 2026.[13]

Read the full Anecdote Library →

The Runway Is the Opportunity

Enforcement doesn't begin until November 12, 2026. That window exists so people can be heard. If non-intoxicating CBD & CBG access matters to you or someone you love, learn the facts, share your story, and tell your representatives.

Share or read a story

Sources

  1. Herb — "The Farm Bill Loophole Is Closing" — herb.co/news/farm-bill-loophole
  2. LAPPA Fact Sheet — "Closing the Hemp Loophole" — legislativeanalysis.org
  3. Forbes — "Congress Bans Delta-8 & THCA Under New Hemp Law" — forbes.com
  4. Vicente LLP — "2026 Federal Hemp Ban" — vicentellp.com
  5. marijuana.net — "Federal Hemp Ban 2026: What Becomes Illegal Nov 12" — marijuana.net
  6. ProCannabis — "Hemp Ban 2025: What Takes Effect November 2026" — procannabis.com
  7. Epidiolex (official) — epidiolex.com
  8. Abu-Sawwa et al., J Pediatr Pharmacol Ther (2020), "Emerging Use of Epidiolex (Cannabidiol) in Epilepsy" — PMC7439947
  9. Blessing et al., Neurotherapeutics (2015), "Cannabidiol as a Potential Treatment for Anxiety Disorders" — PubMed 26341731
  10. Cuttler et al., Scientific Reports (2024), "Acute effects of cannabigerol on anxiety, stress, and mood" — PMC11246434
  11. WFAA — "A desperate North Texas mom turned to CBD…" (2026) — wfaa.com
  12. Epilepsy Association — "Texas THC ban threatens access for epilepsy patients, veterans" — epilepsyassociation.com
  13. Austin American-Statesman Editorial Board — "Hemp ban harms veterans, small businesses" (2026) — via Yahoo News